{"ORPHApacket":[{"ORPHApacketID":"163525","date":"2019-12-05 22:58:43","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"163525","Name":[{"lang":"en","label":"Subacute cutaneous lupus erythematosus"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_163525","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare cutaneous lupus erythematosus"}],"ORPHA":"535","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_535"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A form of cutaneous lupus erythematosus (CLE) that can present either as a non-scarring, annular photo-distributed dermatosis or psoriasiform plaques. This disorder is associated with anti-Ro\/SSA antibodies and can be drug-induced."}]}]}